EUVIMEDEUVIMED entdecken
Crossref

Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations

Guilherme Suarez-Kurtz iD, Claudio José Struchiner iD

Pharmacogenomics · 2024

DOI: 10.2217/pgs-2024-0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacogenomics, 2024. Verfasst von Guilherme Suarez-Kurtz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Pharmacogenetics, South American People, Tacrolimus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study shows that the distribution of CYP3A5 alleles (*1, *3, *6 and *7) and genotype-predicted CYP3A5 phenotypes vary significantly across Latin American cohorts (Brazilians and the One Thousand Genomes Admixed American superpopulation), as well as among subcohorts comprising individuals with the highest proportions of Native, European or sub-Saharan African ancestry. Differences in biogeographical ancestry across the study groups are the likely explanation for these results. The differential distribution of CYP3A5 phenotypes has major pharmacogenomic implications, affecting the proportion of individuals carrying high risk CYP3A5 phenotypes for the immunosuppressant tacrolimus and the number of patients that would need to be genotyped to prevent acute rejection in kidney transplant recipients under tacrolimus treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacogeneticsSouth American PeopleTacrolimusHumansCytochrome P-450 CYP3AGenotypeGraft RejectionImmunosuppressive AgentsLatin AmericaPhenotypePolymorphism, Single NucleotideIndigenous PeoplesWhite PeopleSub-Saharan African People

Stichwörter der Autor:innen

CYP3A5Latin American populationsbiogeographical ancestryhigh-risk CYP3A5 phenotypestacrolimus

Substanzen

CYP3A5 protein, humanCytochrome P-450 CYP3AImmunosuppressive AgentsTacrolimus

Autor:innen und Institutionen

  • Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
  • Escola de Matemática Aplicada, Fundação Getúlio Vargas, Rio de Janeiro, RJ, Brazil.

ORCID-Profile: Guilherme Suarez-Kurtz, Claudio José Struchiner

Zitieren

APA

Suarez-Kurtz, G., & Struchiner, C. J. (2024). Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations. Pharmacogenomics. https://doi.org/10.2217/pgs-2024-0009

Vancouver

Suarez-Kurtz G, Struchiner CJ. Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations. Pharmacogenomics. 2024. doi:10.2217/pgs-2024-0009

BibTeX
@article{SuarezKurtz2024,
  author = {Suarez-Kurtz, Guilherme and Struchiner, Claudio José},
  title = {Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations},
  journal = {Pharmacogenomics},
  year = {2024},
  doi = {10.2217/pgs-2024-0009}
}
Kostenlos starten →